CIK 0001367083 · Non-accelerated filer<br>Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680423298
- Phone
- 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-30 | Harrison Russell Joseph Director | Grant or award | +895 | 10,905 | ||
| 2017-05-30 | Birnbaum Jay E Director | Grant or award | +612 | 9,161 | ||
| 2017-05-30 | BARBARI SHARON SURREY Director | Grant or award | +754 | 9,958 | ||
| 2017-04-03 | Umscheid Marc Chief Strategy/Mkt Officer | Grant or award · Stock option (right to buy) | +17,000 | 72,000 | ||
| 2017-04-03 | Schutz James J Chief Executive Officer | Grant or award · Stock option (right to buy) | +30,000 | 133,658 | ||
| 2017-04-03 | Northey Robert Allen Exec. VP of Res & Development | Grant or award · Stock option (right to buy) | +17,000 | 60,310 | ||
| 2017-04-03 | Miller Robert E Chief Financial Officer | Grant or award · Stock option (right to buy) | +30,000 | 140,866 |
Page 7 of 7 · 127 trades